Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

The combination therapy was effective and well-tolerated, especially in young patients.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Thyroid hormone receptor β1 is found in human hair follicles and helps them survive.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Thallium poisoning is serious, affecting nerves and organs, and is treated by reducing absorption and removing it from the body.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

Skin stem cells were turned into heart cells using a chemical, suggesting a new way to treat heart attacks.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Thymosin β4 helps in cell activities, healing, and organ preservation, and treats hair loss and skin injuries.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Eyebrow follicles are best for accurate genetic testing after stem cell transplants.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

New therapies are being developed that target integrin pathways to treat various diseases.